Stem Cell Agency Governing Board Meeting 3/29/10

Mar 29, 2010
Main Location: 

CIRM
210 King Street, 3rd Floor
San Francisco, CA 94017

Additional Locations: 
ValleyCare Health System 5575 West Las Positas Blvd. Suite 300 Pleasanton, CA 94588
City of Hope 1500 E. Duarte Road Duarte, California 91010
San Francisco City Attorney's Office San Francisco International Airport International Terminal, 5th Floor San Francisco, CA 94128
330 Plaza Street Healdsburg, CA 95448
UC Berkeley 119 California Hall Berkeley, CA 94720
UC Davis School of Medicine 4610 X Street, Suite 3101 Sacramento, CA 95817
Salk Institute 10010 North Torrey Pines Road La Jolla, CA 92037
628 Pacific View Drive San Diego, CA 91209
7257 Beverly Blvd., Suite 218 Los Angeles, CA 90036
2101 Forest Avenue, Suite 225 San Jose, CA 95128
UCSF School of Medicine 513 Parnassus Avenue, Room S224 San Francisco, CA 94143-0410
136 Roanoke Street San Francisco, CA 94131
UC San Diego School of Medicine Dean's Office 9500 Gilman Drive La Jolla, California 92093-0602
Keck School of Medicine of the University of Southern California 1975 Zonal Avenue KAM 500 Los Angeles, CA 90033
Onyx Pharmaceuticals, Inc. 2100 Powell Street Emeryville, CA 94608
Cedars-Sinai Medical Center 8635 West Third St., Ste 160W Los Angeles, CA 90048
Stanford University Clark Center 318 Campus Drive Stanford CA, 94305
CONNECT 8950 Villa La Jolla Drive Suite A-124 La Jolla, CA 92037
Reeve-Irvine Research Center 1105 Gillespie Neuroscience Research Facility (GNRF) 837 Health Science Road University of California at Irvine School of Medicine Irvine, CA 92697-4292
Alta Partners One Embarcadero Center 37th Floor San Francisco, CA 94111
8170 Laguna Blvd # 215 Elk Grove, CA 95758
140 Holiday Vista Drive Mammoth Lakes, CA

State Stem Cell Agency Meeting Notice and Agenda

SPECIAL MEETING OF THE
INDEPENDENT CITIZENS’ OVERSIGHT COMMITTEE (“ICOC”)
TO THE CALIFORNIA INSTITUTE FOR REGENERATIVE MEDICINE

Organized Pursuant To The
CALIFORNIA STEM CELL RESEARCH AND CURES ACT

OPEN SESSION

1. Call to Order.

2. Roll Call.

[Members of the Public will be invited to provide testimony before or during consideration of each agenda item. Speakers are asked to limit their testimony to three (3) minutes.]

CLOSED SESSION

3. Discussion of Personnel (Government Code section 11126, subdivision (a); Health & Safety Code section 125290.30(d) (3) (D)).

OPEN SESSION

4. Consideration of compensation terms of Vice President of Research & Development.

5. Consideration of guidance and CIRM’s Medical and Ethical Standards regarding use of previously NIH approved lines in CIRM-funded research and additional lines that are comparable to CIRM’s recommendations to the NIH and/or would be grandfathered or approved under those recommendations.

6. Public comment. The Committee will accept public testimony on any matter under its jurisdiction that is not on the agenda, but the Committee cannot act on any such matter at this meeting.


THE ORDER OF BUSINESS MAY BE CHANGED WITHOUT NOTICE.
Notice is hereby given that the order of consideration of matters on this agenda may be changed without prior notice.

**NOTICE**

The California Institute for Regenerative Medicine and its Independent Citizens Oversight Committee, and any subcommittees thereof, comply with the Americans with Disabilities Act (ADA) by ensuring that the meeting facilities are accessible to persons with disabilities, and providing that this notice and information given to the Members of the Committee is available to the public in appropriate alternative formats when requested. If you need further assistance, including disability-related modifications or accommodations, you may contact Melissa King at the California Institute for Regenerative Medicine at 415-396-9100 no later than the day prior to the meeting.

Questions or requests for additional information prior to the Independent Citizens Oversight Committee meeting may be referred to Melissa King at the California Institute for Regenerative Medicine at mking@cirm.ca.gov or 415-396-9100.

This meeting agenda is also available on the website for the California Institute for Regenerative Medicine at http://www.cirm.ca.gov .
 

Transcripts: 

© 2013 California Institute for Regenerative Medicine